To further see the role of FOXO1 in PI3K/AKT/mTOR pathway of DLBCL, we examined if FOXO1 had an inhibitory effect on mTOR activity as previously reported in other types of cells [29, 30]. The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.